Marksans Pharma Board Meeting Scheduled on May 26, 2026 to Approve Q4FY26 Financial Results and Consider Dividend

Marksans Pharma has notified the stock exchanges of an upcoming board meeting scheduled for Tuesday, May 26, 2026, at Mumbai. The intimation has been filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will address key financial and corporate matters pertaining to the concluded fiscal year.

Key Agenda Items

The board meeting has been convened to transact the following businesses, as detailed in the regulatory filing:

Agenda Item: Details Financial Results: Audited Standalone and Consolidated results for the Quarter and Year ended March 31, 2026 Dividend Consideration: Recommendation of dividend on equity shares for FY2025-26, if any Meeting Date: Tuesday, May 26, 2026 Meeting Location: Mumbai

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's Internal Code on Prohibition of Insider Trading, the trading window for dealing in the company's shares has been closed for Designated Persons, including Directors, and their immediate relatives. The key details of the trading window restriction are as follows:

Closure Date: April 01, 2026

Re-opening Date: Forty-eight hours after the announcement of financial results, i.e., up to May 28, 2026 (both days inclusive)

Regulatory Compliance and Disclosure

As required under the Listing Regulations, the board meeting intimation is available on the company's official website at www.marksanspharma.com , as well as on the websites of BSE Limited and the National Stock Exchange of India Limited. The filing was signed by Harshavardhan Panigrahi, Company Secretary, on May 12, 2026. The company is headquartered at the 11th Floor, "GRANDEUR", Oshiwara, Andheri (W), Mumbai – 400 053.

Marksans pharma Limited has submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The pharmaceutical company filed the mandatory documentation with both BSE and NSE on April 09, 2026, demonstrating its commitment to regulatory compliance.

Regulatory Compliance Details

The certificate was issued by Bigshare Services Private Limited, the company's appointed Registrar and Transfer Agent, on April 06, 2026. This documentation is required under the SEBI (Depositories and Participants) Regulations, 2018, specifically addressing the proper handling of securities dematerialization processes.

Parameter Details Regulation SEBI Regulation 74(5) Quarter Ended March 31, 2026 Filing Date April 09, 2026 Registrar Bigshare Services Private Limited Company Secretary Harshavardhan Panigrahi

Certificate Confirmation

Bigshare Services confirmed that all securities received from depository participants for dematerialization up to March 31, 2026 were properly processed. The registrar verified that:

Securities received for dematerialization were confirmed to depositories within regulatory timelines

All securities are listed on stock exchanges where the company's earlier issued securities are traded

Security certificates received for dematerialization were mutilated and cancelled after proper verification

Depository names were substituted in the register of members as registered owners within 15 days of certificate receipt

Stock Exchange Communication

The company communicated with both major Indian stock exchanges regarding this compliance filing. BSE Limited received the documentation at its Corporate Relation Department, while NSE's Listing Department was notified of the regulatory submission.

Corporate Information

Marksans Pharma Limited operates from its registered office located at the 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri West, Mumbai. The company maintains regular communication with stakeholders through its dedicated investor relations channels and ensures timely compliance with all regulatory requirements.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.